about
Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cellsKey implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subsetThe Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific AntibodiesThe Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T CellsSelf/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.Molecules and Mechanisms Implicated in the Peculiar Antigenic Activation Process of Human Vγ9Vδ2 T CellsVγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.Synergism and complementarity between human CD1 AND MHC-restricted T cells, two lymphoid subsets directed against distinct antigenic worlds.Human Vgamma9Vdelta2 T cells: promising new leads for immunotherapy of infections and tumors.Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human Vδ3 T cells.Stereotaxic administrations of allogeneic human Vγ9Vδ2 T cells efficiently control the development of human glioblastoma brain tumors.Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemiaModulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?Sensing of cell stress by human γδ TCR-dependent recognition of annexin A2.Butyrophilin 3A (BTN3A, CD277)-specific antibody 20.1 differentially activates Vγ9Vδ2 TCR clonotypes and interferes with phosphoantigen activation.Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells.CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis.NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.Efficient Mitochondrial Glutamine Targeting Prevails Over Glioblastoma Metabolic Plasticity.The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.IL-21 Increases the Reactivity of Allogeneic Human Vγ9Vδ2 T Cells Against Primary Glioblastoma Tumors.Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.The interplay between the duration of TCR and cytokine signaling determines T cell polarizationMolecular regulation of CC-chemokine receptor 3 expression in human T helper 2 cellsTumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-IDevelopment of Predictive Value of Urinary Cytokine Profile Induced During Intravesical Bacillus Calmette-Guérin Instillations for Bladder CancerImpact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantationNKG2D Controls Natural Reactivity of Vγ9Vδ2 T Lymphocytes against Mesenchymal Glioblastoma CellsCombined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells in vivoStereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme XenograftsAn X-ray Vision for Phosphoantigen Recognition
P50
Q24336997-9A3EEA3D-B1B4-4F6F-99BA-E5FE26D9A98AQ24339540-91CF987A-9C9C-4B5D-9F57-F7C4CEA54547Q27670973-3E7FB40E-2239-4D6C-BF86-FFE6CCA49DB9Q27682926-68385750-7FE0-4CF3-9D63-5571A7FDF06EQ28287583-7632E611-455F-4E68-894F-E5AE9BD38FA9Q34412732-3A88A1E8-7815-4CF4-A494-575239F5697DQ34819275-68D40254-EE47-4991-AAF4-B9B352DE155FQ34936375-0B57A043-88AD-491F-B205-8717231C3E4AQ35966305-094175A7-8011-4408-9879-742EFAEAB473Q36548005-5189FDD6-6BF2-43A9-AA36-B383DED6971AQ36986689-7A938EF9-4CBC-40B6-B83A-EC363EC8234CQ37039445-934D81BD-6058-47EA-95D6-9D605FAB200DQ37079078-D81E69DC-FC6C-407B-A62B-DE6E90566578Q37175814-49ECB7C5-291B-47B4-88CD-691E8E6CE62AQ37279963-F684E150-EA15-4612-A503-40F145798C51Q37380386-A0E96044-93A7-4347-A40A-2F7B1C4D3CF1Q37580081-3104DD47-7188-4BAC-AAC8-D52188814ACBQ37730154-17ED5361-EAE0-433E-9E52-99733693BA49Q38848635-CD00995E-EB30-4052-B55A-99788ABF570DQ38896801-088C112B-E7F3-4E2A-A76B-D72AE000666AQ38984211-1683503A-F2A5-476B-976E-7DCBEFA7BE8AQ39698695-A742DA6A-283D-4D8D-9695-843CAC7CE2C7Q39876506-4FB13405-93DE-4EAA-938B-519715E6CD16Q40267794-EA88B4B6-C72C-4F7E-B088-9E8B180F3AC4Q40381596-1917F288-B148-458F-9845-4DF91E806ED9Q42080041-69F5C7D7-BEDA-475B-B14E-9517843DCA62Q48190039-FAF474FC-204B-498E-8F01-314346CCA62CQ48210050-EF75F492-C21E-433F-9562-0E47CACD38BBQ52570151-2651E2DF-471B-49D0-92E0-F27C2FCF0683Q54219852-AB3ED4DE-338E-4411-B0B3-DB632F5B4006Q64936291-EAE000FF-4BF5-46A4-AE40-9F72F81F8FA2Q73281837-AFDE1C32-105C-49DB-828A-288096023664Q74595848-CEAAC2D5-C66F-472A-BB57-583B367E0835Q81304839-56E831DB-0E37-4F25-A823-63D5FFF37236Q86860323-EF937078-FAC7-4E00-A211-658AB65687C3Q88074414-DA790BE1-89B9-44EA-8F56-6E48F0B4A958Q90044403-3F33A233-E723-44B1-A6FB-927276AFB85AQ90913534-78F692AD-45B5-47AC-8F1D-D50EEEAAD62EQ91479987-9B857D5F-B911-43AB-8F79-A0973D5743D9Q93158259-F4E3E309-E184-4076-AB90-B7BBBC8FD41C
P50
description
researcher ORCID ID = 0000-0001-8010-9556
@en
wetenschapper
@nl
name
Emmanuel Scotet
@ast
Emmanuel Scotet
@en
Emmanuel Scotet
@es
Emmanuel Scotet
@nl
type
label
Emmanuel Scotet
@ast
Emmanuel Scotet
@en
Emmanuel Scotet
@es
Emmanuel Scotet
@nl
prefLabel
Emmanuel Scotet
@ast
Emmanuel Scotet
@en
Emmanuel Scotet
@es
Emmanuel Scotet
@nl
P106
P31
P496
0000-0001-8010-9556